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Abstract
Background: Of the 5 484 predicted proteins of Plasmodium falciparum, the main causative agent
of malaria, about 60% do not have sufficient sequence similarity with proteins in other organisms
to warrant provision of functional assignments. Non-homology methods are thus needed to obtain
functional clues for these uncharacterized genes.
Results: We present PlasmoDraft http://atgc.lirmm.fr/PlasmoDraft/, a database of Gene Ontology
(GO) annotation predictions for P. falciparum genes based on postgenomic data. Predictions of
PlasmoDraft are achieved with a Guilt By Association method named Gonna. This involves (1) a
predictor that proposes GO annotations for a gene based on the similarity of its profile (measured
with transcriptome, proteome or interactome data) with genes already annotated by GeneDB; (2)
a procedure that estimates the confidence of the predictions achieved with each data source; (3) a
procedure that combines all data sources to provide a global summary and confidence estimate of
the predictions. Gonna has been applied to all P. falciparum genes using most publicly available
transcriptome, proteome and interactome data sources. Gonna provides predictions for numerous
genes without any annotations. For example, 2 434 genes without any annotations in the Biological
Process ontology are associated with specific GO terms (e.g. Rosetting, Antigenic variation), and
among these, 841 have confidence values above 50%. In the Cellular Component and Molecular
Function ontologies, 1 905 and 1 540 uncharacterized genes are associated with specific GO terms,
respectively (740 and 329 with confidence value above 50%).
Conclusion:  All predictions along with their confidence values have been compiled in
PlasmoDraft, which thus provides an extensive database of GO annotation predictions that can be
achieved with these data sources. The database can be accessed in different ways. A global view
allows for a quick inspection of the GO terms that are predicted with high confidence, depending
on the various data sources. A gene view and a GO term view allow for the search of potential GO
terms attached to a given gene, and genes that potentially belong to a given GO term.
Background
Malaria is one of the most prevalent disease in the world,
infecting 400 million people every year, and causing 2.7
million deaths, mainly children under 5 years [1]. Plasmo-
dium falciparum, the main causative agent of this parasitic
disease, develops drug resistance and no effective vaccine
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is available. Of the 5 484 coding genes of P. falciparum
(http://plasmodb.org version 5.4), about 60% do not
have sufficient similarity to proteins in other organisms to
warrant provision of functional assignments. Thus,
almost two-thirds of the proteins appear to be specific to
P. falciparum, a much higher proportion than observed in
other enkaryotes [2]. However, this is likely exacerbated
by the high evolutionary distance between P. falciparum
and other sequenced eukaryotes, so homology detection
is a hard task. Because of the extreme AT bias (80%), the
high amino acid bias (six amino acids account for more
than 50% of the protein composition) and the presence of
a large number of low complexity repeat regions that are
believed to form non-globular segments [3], standard
sequence comparison methods based on BLAST [4] or
HMMER [5] could be ineffective [6]. Non-homology
methods are thus needed to obtain functional clues for
these uncharacterized genes [7].
Methods based on post-genomic data (mainly gene
expression and protein interaction) have been proposed.
These are commonly called Guilt by Association (GBA)
methods. Contrary to sequence homology which involves
inter-species annotation transfers, i.e. genes characterized
in other species are used to annotate genes of the newly
sequenced genome, GBA approaches involve intra-species
annotation transfers: the genes already characterized in
the genome, e.g. by wet experiments or using sequence
homology, are used for the annotation of the other genes
(guilt by association principle). Gene expression data are
often used, since genes with similar transcriptomic pro-
files likely share common functional roles [8,9]. In the
same way, protein interaction data are also used since pro-
teins that share common interactors likely share common
functions [10-12]. These methods provide functional pre-
dictions for the uncharacterized genes, and new clues to
be compared with the predictions achieved by homology.
Part of these new post-genomic methods work in a non-
supervised way: first a gene clustering algorithm is run on
the post-genomic data to cluster the genes into several
groups. Then, in each cluster and for each potential func-
tion, a statistical test is applied to compare the proportion
of genes annotated with this function in the cluster with
that in the complete set of genes. Functions that appear to
be over-represented in one cluster are used to annotate the
uncharacterized genes that belong to this cluster. Several
genome-scale studies have been conducted using this
principle, e.g. [8,13,14].
Some other GBA methods work in a supervised way: first,
based on the post-genomic data of already characterized
genes, a supervised learning algorithm is run to learn a
predictor, i.e. a function that takes post-genomic measure-
ments of a given gene as input, and outputs one or several
functional predictions for that gene. This predictor is then
used to annotate the uncharacterized genes. Typical exam-
ples of this approach are, e.g. [11,15,16]. Zhou et al. [17]
presented OPI, a supervised method that predicts Gene
Ontology annotations using gene expression profiles and
was applied on P. falciparum. Alternative methods work in
a semi-supervised way [18]; these use gene clustering as in
the non-supervised approach, but clustering is not fully
unsupervised as the function of the already characterized
genes is used to define the clusters.
In this paper, we present PlasmoDraft http://
atgc.lirmm.fr/PlasmoDraft/, a database of Gene Ontology
(GO) annotation predictions for P. falciparum achieved by
applying a GBA predictor named Gonna (for Gene Ontol-
ogy Nearest Neighbor Approach) on several transcriptome
(microarray), proteome (mass-spectrometry) and protein-
protein interaction data. The Gonna system involves: (1)
a supervised k-nearest-neighbor predictor that proposes
predictions on the basis of each data source; (2) a cross-
validation procedure that estimates the confidence of the
predictions achieved with each data source; (3) a proce-
dure that combines the results achieved with the different
data sources to estimate a global confidence value of each
prediction for each gene. The PlasmoDraft database pro-
vides all of these predictions along with their confidence
values in a friendly interface that allows easy browsing
and querying.
Methods
Gonna proposes annotation predictions in the GO frame-
work. The GO Consortium http://www.geneontology.org
has developed a systematic and standardized nomencla-
ture to annotate genes in terms of their associated biolog-
ical processes (BP), cellular components (CC) and
molecular functions (MF), in a species-independent man-
ner. Each ontology describes generalization relationships
between hundreds of terms. The most general term is at
the top of the ontology, while the bottom terms are the
most specific ones. A gene may be annotated with several
GO terms of the same ontology. Moreover, due to the gen-
eralization relationship, when a gene is annotated with a
term t, then it is also annotated with all upper terms that
generalize t (a principle known as the "true path rule" in
GO context). In PlasmoDraft, the specificity of a term is
evaluated by its prior probability, i.e. the proportion of
already characterized genes of P. falciparum that belong to
this term. In this way, the leaves of the ontologies are the
most specific terms with low prior probabilities, while the
root of the ontology is the most common term with a
prior probability of 1. Gonna uses the GO annotations
available on PlasmoDB and provided by GeneDB as prior
knowledge database to propose new annotations. The GO
consortium distinguishes between curator-assigned anno-
tations and automatically-assigned annotations. Curator-BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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assigned annotations involve annotations that come from
experimental data (GO evidence codes IDA, IPI, etc.), or
that have been inferred by sequence similarity and curated
by an expert (GO evidence code ISS). Automatically-
assigned annotations involve all electronically inferred
annotations (usually by sequence similarity) that have
not been reviewed by an expert (GO evidence code IEA).
Here, due to the scarcity of the curator-assigned annota-
tions for P. falciparum (~60% annotations possess IEA evi-
dence code only), all available GO annotations are
considered, without regard to their evidence code (this
choice is further-discussed below). Every gene with an
annotation in the considered ontology (whatever its evi-
dence code) is then referred as "characterized".
The predictor
Gonna uses a k-nearest neighbor approach [19]. It takes as
input two positive integers K and K' ≤ K (e.g. K = 6 and K'
= 4), one ontology (MF, BP, or CC), and one postgenomic
data source D (e.g. the microarray data of [14]). With this
data source, Gonna computes a function SD that measures
the similarity SD (g, h) of every gene pair (g, h). For exam-
ple, if D is a transcriptomic data set then SD measures the
similarity of profiles using the Pearson correlation coeffi-
cient. When asked for the GO categories of a gene g,
Gonna uses the SD function to search for the K  genes
already characterized in the selected ontology by GeneDB,
which have the highest level of similarity with g. Then, for
each GO term t of the ontology, Gonna looks at these K
genes, and if at least K' are associated with t, then g is pre-
dicted to be also associated with t; otherwise g is not con-
sidered to be in t. Note that when looking at the terms
associated with the neighbor genes, Gonna considers all
the upper terms generalizing the direct annotations (i.e.
all terms in the true path rule).
Some choices are critical to insure that Gonna provides
relevant and accurate predictions. The first critical choice
is related to the similarity measure, which has to capture
the "signature" of the gene functions in the data set at
hand. When two genes appear to be similar, this should
imply that they share common functions. For transcrip-
tomic (microarray) and proteomic (mass-spectrometry)
data, we use the Pearson correlation coefficient that gives
high similarity to genes with correlated transcriptomic/
proteomic profiles. Other similarity measures, as the clas-
sical Euclidean metric, could be possible, but the Pearson
correlation measure has been shown to perform well to
detect functional links in several analyses [20]. For the
protein-protein interaction data, we use the Czekanovski-
Dice metric [21], which gives high similarity to pairs of
genes that share many interactors, and has been shown to
perform well to predict biological functions [10].
Another critical choice is related to the K and K' values. K
should be neither too large (else some neighbors will not
be similar to the studied gene) nor too low (to avoid
reduced, non-representative gene samples). With K' the
problem is different. If K' is high (close to K), then the
proportion of good predictions is likely to be high, but
only a few predictions could be achieved on the most spe-
cific terms of the ontology, and most of the predictions
would involve the most general (and hence less interest-
ing) terms. Conversely, if K' is low, then the proportion of
good predictions declines, but more predictions are made
on the most specific terms. In PlasmoDraft, we use two
pairs of parameters (K,  K') for each postgenomic data
source: one stringent pair (K = 6, K' = 4) is used to achieve,
for each GO term, a first set of predictions that usually has
a high proportion of good predictions (see next section
for an estimate of this proportion). Next, a second, non-
stringent pair (K = 6, K' = 2) is used to come up with, for
each GO term, another set of predictions that cannot be
achieved with the stringent setting, but which usually con-
tains a lower proportion of good predictions.
This k-nearest neighbor predictor has several appealing
features. It is a direct and simple implementation of the
GBA principle, which allows the predictions to be
explained by exhibiting the K'  genes annotated by
GeneDB that support each prediction (see Figure 1). In
fact, Gonna uses a basic principle similar to gene expres-
sion mining tools as g:profiler [22], which help users to
make their own predictions. These tools search for genes
with expression profile correlated with that of the studied
gene, look for GO terms enriched in the neighboring gene
list, and then predict the selected GO terms for the studied
gene. Gonna can thus be viewed as a systematic and auto-
matic implementation of this natural principle, combined
with confidence estimation and data source aggregation
(see below). Moreover, Gonna can be used with any
present and future postgenomic data source, as long as
there is a relevant similarity measure. Next. Gonna is con-
sistent with the structure of the ontology. This important
property means that if any gene is predicted in a GO term
t, then it must be predicted in all terms that generalize t.
Finally, Gonna has low computing time, which enables
intensive use of the cross-validation procedure to assess
the confidence of the predictions.
Assessing the predictions
Cross-validation (CV) is a well known procedure to esti-
mate the error rate of supervised classification methods
[19]. The leave-one-out version of CV, which we use here,
involves: (1) running Gonna on each gene already charac-
terized in GeneDB as if it were an uncharacterized gene,
and (2) comparing the predictions to the true annota-
tions. Since no functional information on this gene is sup-
plied to Gonna for the predictions, this procedure
provides an unbiased estimate of the method perform-
ance [19]. For a given GO term t, the correct predictions in
CV involve the genes predicted in t, which are alreadyBMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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annotated by this term in GeneDB (or by a specialization
of t, cf. the true path rule); the wrong predictions involve
the genes predicted in t which are already annotated in the
ontology under consideration (MF, BP, or CC) but not
with t (or one of its specializations). Genes without any
annotation in the selected ontology are not taken into
account. It is convenient to present all of these quantities
in tabular form (see Table 1). For example, pa denotes the
number of genes predicted in the GO term t which are
annotated with t in GeneDB, while nn denotes the number
of genes not annotated with t which have not been pre-
dicted in t in CV. Then, the True Discovery Rate (TDR)
associated with this GO term (and for a given data source)
is estimated by
TDR = pa/(pa + pn). (1)
For example, a GO term with a TDR of 80% means that
when Gonna predicts that a gene belongs to this term, this
prediction has 80% chance of being correct. Note that due
to the incompleteness of the annotations, the above for-
mula may be a conservative estimate of the TDR, because
some predictions considered as wrong may actually be
correct. Moreover, when the sample size (pa + pn) is low.
this TDR estimate may not be fully accurate. So, we also
compute the p-value of achieving by chance pa or more
correct predictions (among pa + pn) if the true TDR were
equal to the prior probability of the term. If this p-value is
higher than 5%, then the TDR is not considered to be sig-
nificantly higher than the prior probability. PlasmoDraft
reports the TDRs of the predictions with a color code that
ranges from red (0%) to light green (100%) via yellow
(50%), while non-significant TDRs appear in gray (cf Fig-
ure 2). As described above, two sets of predictions are
achieved for each GO term and data source using two
parameters K'. Therefore, one TDR is estimated for each of
these sets: the first TDR reports the accuracy of the predic-
tions achieved with the stringent predictor, while the sec-
The neighbors view Figure 1
The neighbors view. Profiles of the K nearest characterized neighbors that support (white), or does not support (gray), the 
prediction of gene PFL0020w in term Adhesion to other organism during symbiotic interaction 
(GO:0051825) for the Leroch et al. (2003) data source [14]. For comparison purpose, profiles of the K nearest uncharacter-
ized neighbors (yellow) are also reported.BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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ond TDR reports the accuracy of the predictions achieved
with the non-stringent predictor but which are not sup-
ported by the stringent one. As expected, the first TDR is
usually higher than the second one. When neither the
stringent predictor nor the non-stringent one apply, the
gene is said to be "non predicted in t".
The advantage of estimating the TDR of each GO term
rather than estimating a global performance on the whole
ontology is that it allows to differentiate GO terms that
appear well suited for applying a GBA approach with the
considered data source. Indeed, all GO terms cannot be
predicted with the same accuracy. First because some
terms are more general than others (and thus are a priori
more likely). But also because some functions (GO terms)
have a more apparent signature than others in the consid-
ered data source. For example, while they have a similar
prior probability (~10%), GO terms antigenic vari
ation (GO:0020033) and post-translational
protein modification (GO:0043687) get 90%
and 15% TDRs with the microarray data of [14], respec-
tively.
Combining the data sources
When each data source has been used to produce predic-
tions, and TDRs have been estimated for each GO term
and each source, Gonna combines all of these results to
propose a Global Degree of Belief (GDB) for each predic-
tion. If gene g has been predicted to be associated with GO
term t by one or several sources, Gonna computes the
GDB of this prediction in the following way. Let 1,..., n
and n + 1,..., m denote the data sources that support, and
do no support, the prediction of g in t, respectively. We
use the notation di and ¬dj to indicate that data sources i
and j support and do not support the prediction of g in t,
respectively. We first compute a global confidence score
that is a rough estimate of the probability that the predic-
tion is correct, given that it is supported by data sources
1,..., n but not by data sources n + 1,..., m. Using Bayes the-
orem, this probability can be written as
P(t) is the prior probability of term t (estimated by the
proportion of already characterized genes of P. falciparum
that belong to t). P(d1,..., dn, ¬dn+1,..., ¬dm|t) is the proba-
bility that data sources 1,..., n and data sources n + 1,..., m
support and do not support the prediction of g in t when
g belongs to t, respectively. We use the conditional inde-
pendence assumption [19] to estimate this latter term and
the probability P(d1,..., dn, ¬dn+1,..., ¬dm):
and
Terms  P(di|t),  P(¬di|t),  P(di|¬t), and P(¬di|¬t) are esti-
mated with the quantities computed in the CV and dis-
played in Table 1. For example, P(di|t) is the probability
that data source i supports t when the gene belongs to t; it
is estimated by the ratio pa/(pa + na). P(¬di|¬t) is the prob-
ability that data source i does not support t when the gene
does not belongs to t; it is estimated with nn/(pn + nn).
Thus, from the three above equations, the conditional
probability of t can be roughly estimated and it constitutes
our global confidence score. This score reflects the likeli-
hood of the predictions: genes with high (near 1) confi-
dence scores are more likely to be associated with t than
genes with low (near 0) confidence scores. However, due
to the independence assumption, this score cannot be
interpreted as the probability of t. Hence, it is discretized
in 4 score categories (very low [0.0, 0.25], low ]0.25, 0.5],
high ]0.5, 0.75], and very high ]0.75,1.0]). The true dis-
covery rate associated with each category is estimated by
way of a last cross-validation procedure: this is done by
computing the proportion of successes among already
characterized genes that have been predicted in the con-
sidered GO term with a confidence score in this category.
These cross-validated true discovery rates then represent
our GDB. For example, a prediction associated with a GDB
of 80% means that 80% of the predictions belonging to
the same score category in this GO term are correct in the
CV procedure. As for the TDRs, we also compute the p-
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Table 1: Correct and wrong predictions associated with a given 
GO term t in the CV procedure
predicted in not predicted in
annotated with pa na
not annotated with pn nn
pa and pn denote the number of genes predicted in the GO term t 
which are, and are not, annotated with t in GeneDB, respectively. na 
and nn denote the number of genes not predicted in t which are. and 
are not, annotated with t, respectively.BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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value of the GDBs. If this p-value is higher than 5%, then
the GDB is not considered to be significantly higher than
the prior probability of the term, and it appears in gray in
PlasmoDraft.
The discretization procedure we use, sometimes known as
the equal interval width method, could be replaced by other
methods, such as the equal frequency interval method or
more sophisticated methods based on entropy minimiza-
tion [23]. However, it is a classical and simple method
that has shown to give good performance on numerous
data sets [24].
The independence assumption is often used in statistical
machine learning, and forms the basis of the "naive
Bayes" predictor, which was shown to be fairly accurate in
a number of applications [19]. One interesting feature of
this predictor (and hence of the GDB) is that it is not
much affected by irrelevant or poor quality data sources
[25]. Indeed, when a source i is not relevant for a specific
GO term t, either because it has not been designed for
screening this type of information or because of the poor
quality of the data, terms P(di|t) and P(di|¬t) tend to be
equal. Therefore, the numerical quantities related to this
data source tend to cancel in the numerator and denomi-
nator pairs of the confidence score. This prevents the GDB
from pollution by irrelevant or too noisy data sources.
Results
Data
To produce the PlasmoDraft database, Gonna has been
applied to most publicly available postgenomic data
sources we were aware. 9 transcriptomic (microarray), 1
proteomic (mass-spectrometry), and 1 protein-protein
interaction data sets were used. Below is a short descrip-
tion of each data set, indexed by the name used in Plasm-
oDraft.
￿ LE03: Le Roch et al. (2003) data set [14]. A transcrip-
tomic data set that covers 9 stages of the entire cycle of
strain 3D7: 6 asexual intraerythrocytic stages, plus the
merozoite, gametocyte, and salivary gland sporozoite
stages. Measurements for ~5 100 genes.
￿ YO3D7: Young et al. (2005) data set [26]. A transcrip-
tomic data set that covers the sexual developmental cycle
(gametocytes) of strain 3D7. Measurements for ~5 100
genes.
￿ YONF54: Young et al. (2005) data set [26]. Same data
set as Y03D7, for strain NF54.
￿ LLHB3: Llinas et al. (2006) data set [27,28]. A transcrip-
tomic data set that covers 48 h of the intraerythrocytic
developmental cycle of strain HB3. Measurements for ~4
200 genes.
An extract of the Biological Process global view Figure 2
An extract of the Biological Process global view. This view presents a summary of all of the best GDBs and TDRs that are 
associated with each GO term and data source. Clicking on any term opens the corresponding GO term view.BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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￿ LLDd2: Llinas et al. (2006) data set [28]. Same data set
as LLHB3, for strain Dd2.
￿ LL3D7: Llinas et al. (2006) data set [28]. Same data set
as LLHB3, for strain 3D7.
￿ DA06: Dahl et al. (2006) data set [29]. A transcriptomic
data set that covers two 48 h life cycles of doxycyclin
treated parasites. Measurements for ~5 300 genes.
￿ SH07: Shock et al. (2007) data set [30]. A transcriptomic
data set analysing mRNA decay during the intraerythro-
cytic developmental cycle. Measurements for ~5 300
genes.
￿ LE07: A transcriptomic data set analysing the parasite
response to choline analog T4 during the intraerythrocytic
life cycle. See series GSE4582 in the NCBI Gene Expres-
sion Omnibus http://www.ncbi.nlm.nih.gov/geo/. Meas-
urements for ~5 100 genes.
￿ LE04: Le Roch et al. (2004) data set [31,32]. A proteomic
data set that covers 7 stages of the entire cycle of strain
3D7: the ring, trophozoite, schizont, merozoite, gameto-
cyte, gamete, and salivary gland sporozoite stages. Meas-
urements for ~2 900 genes.
￿ LA05: LaCount et al. (2005) data set [33]. A protein-pro-
tein interaction data set. Measurements for ~1 300 genes.
The Gene Ontology file (revision 5.754) and the gene
annotations file (revision 1.54) were downloaded from
the GO website.
Accessing the database
Users can access the predictions by browsing the database
or querying for a specific gene, GO term, or keyword.
Results are displayed using three types of views: a global
view, a gene view, and a GO term view. In each view, TDRs
and GDBs are represented with a color code that ranges
from red (0%) to light green (100%) via yellow (50%);
non-significant TDRs or GDBs (see Method) are in gray.
The global views
There is one global view for each gene ontology (Molecu-
lar Function, Biological Process, and Cellular Compo-
nent). A global view (see Figure 2) shows all GO terms of
the selected ontology where predictions are made. These
are represented in a hierarchical way which respects the
ontology structure. Each term is followed by its prior
probability, the best GDB found for a gene predicted in
this term, and the best TDR  associated with each data
source for this term.
The GO term view
The GO term views show all genes that are predicted in
any given term by Gonna (see Figure 3). Two views are
available for each GO term: one for uncharacterized genes
that have no annotation in GeneDB for the ontology at
hand, and the other one for genes that are already anno-
tated in this ontology in GeneDB (but not obligatory with
this term). For the latter, a '+' symbol after the gene name
indicates that the gene is already annotated by the term.
Additional information about predictions is provided by
clicking on a specific TDR. This opens a new window pre-
senting the K genes that support, or do not support, the
prediction for the corresponding data source, along with
their associated profiles (for the transcriptomic and pro-
teomic sources, see Figure 1). A link towards the AmiGO
website http://amigo.geneontology.org allows the user to
quickly retrieve additional information on this term.
The gene view
The gene view displays the different GO terms that are pre-
dicted for each gene by Gonna. These terms are shown in
a hierarchical way which follows the ontology structure
(see Figure 4). There are three gene views for each gene,
which correspond to the three GO ontologies. Each term
is followed by its prior probability, the GDB of the predic-
tion, and the TDRs associated with all data sources that
support it. Moreover, for genes that already possess
GeneDB annotations in the selected ontology, a ' + ' sym-
bol after the term name indicates that this term already
annotates this gene in GeneDB. As for the term view, click-
ing on a specific TDR opens a new window that provides
additional information about the corresponding predic-
tion. A link to PlasmoDB allows the user to quickly
retrieve additional information on this gene. Note that
TDRs and GDBs associated with the terms usually increase
when scrolling toward the top of the ontology, because
the prior probabilities of the terms increase. However,
they may also decrease sometimes: If a GO term t is a gen-
eralization of one term t' with a good postgenomic signa-
ture (high TDR) and one term t" with a poor signature
(low TDR), genes predicted in t" may have an unfavorable
impact on the TDR estimation of t which may be lower
than that of t'.
Discussion
Annotation quality
Quantity and quality of the available annotations used in
the prior knowledge database to generate the predictions
is a key point of any GBA approach. For P. falciparum, both
quantity and quality are questionable. For example, in the
BP ontology, of the 1799 genes (35%) possessing annota-
tions, only 228 (13%) have annotations with experimen-
tal evidence; annotations of the 1571 remaining genes
come from sequence similarity with proteins of other
organisms (ISS and IEA evidence codes), and for 1067BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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genes (68%) these annotations have IEA code, indicating
that they have not been reviewed by a curator. Moreover,
of the 431 different BP GO terms associated with the P.
falciparum genes when considering all annotations, 172
(40%) are associated with IEA annotations only. For
example, all annotations involving BP GO terms ATP
biosynthetic process (GO:0006754), immune
response (GO:0006955) or methylation
(GO:0032259), as well as their descendants terms, pos-
sess IEA code only. Hence, we decided to consider all
available GO annotations when generating the Plasmo-
Draft database. Removing all non-curated annotations
from the prior knowledge database would eliminate not
only numerous characterized genes, but also numerous
GO terms, which would render impossible any new pre-
diction in these parts of the ontology.
Experiments on a well annotated organism
In these conditions, it was relevant to check the method
on a well annotated organism, using only experimental
evidence code annotations as input for the predictions
and for estimating the TDRs. To this end, we applied
Gonna on the transcriptomic data set published by Spell-
man et al. (1998) [34], which monitors the expression
level of yeast genes along the cell cycle. The same param-
eters as for P. falciparum were used, i.e. neighbor genes
were selected using the Pearson correlation coefficient and
we used two sets of parameters (K, K'): (K = 6, K' = 4) and
(K = 6, K' = 2). All annotations different from IEA, ISS and
RCA were used (gene annotation file revision 1.1323,
downloaded from the GO website), which involves 4 165
genes characterized in the BP ontology, and a total of 1
220 different GO terms. The TDRs were estimated for each
GO term by cross-validation. Figure 5 represents the TDRs
associated with all BP GO terms where predictions are
proposed by Gonna, as a function of the prior probability
of the terms. We see that for numerous terms, predictions
are made with a TDR significantly higher than the prior
probability of the term, which shows the potential of the
approach to decipher biological functions from gene
expression data. For comparison purpose, the same exper-
iment was achieved on P. falciparum with the time series
of Bozdech et al. (2003) [27] using all available BP anno-
tations (see Figure 6). While, as expected, the number of
GO terms where predictions are made is lower than for
yeast, numerous GO terms are also predicted with high
TDRs. Though the reliability of these predictions could
depends on the prior (IEA) annotations, the similarity of
Figures 5 and 6 is quite encouraging and shows that P. fal-
An extract of the predictions achieved in term "adhesion to other organism during symbiotic interaction" (GO:0051825) Figure 3
An extract of the predictions achieved in term "adhesion to other organism during symbiotic interaction" 
(GO:0051825). The "no" entry indicates that the data source does not support the prediction, while "-" means that no data 
are available in the source for this gene. By clicking on a TDR, the K characterized nearest neighbors that support/do not sup-
port this prediction are shown (see Figure 1). Clicking on any gene opens the corresponding gene view.BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
Page 9 of 15
(page number not for citation purposes)
ciparum annotations are globally consistent, as they are
mostly recovered using a transcriptomic data set.
Contents of the database
By browsing the PlasmoDraft database, several predic-
tions clearly involve rare GO terms (i.e. with low prior
probability) with high TDRs or GDBs. For example, in the
BP ontology, 16 uncharacterized genes are predicted in
establishment of localization (GO:0051234)
(prior probability 15%, GDB 78%), 25 uncharacterized
genes are predicted in Rosetting (GO:0020013)
(prior probability 2%, GDB 78%), and 50 uncharacter-
ized genes are in Pathogenesis (GO:0009405) (prior
probability 4%, GDB  75%). Similarly (but with lower
GDBs), 13 uncharacterized genes are predicted in Ubiq
uitin-dependent protein catabolic
proces(GO:0006511) (prior probability 2%, GDB
50%), and 12 uncharacterized genes are in
Biopolymecata bolic process (GO:0043285)
(prior probability 3%, GDB  56%). Moreover the best
TDRs are not always achieved with the same data source.
For example, for the Antigenic variation
(GO:0020033) term, the LE03 data [14] provides more
accurate predictions than the LLHB3/LLDd2/L13D7 series
[27,28], may be because this function has a more appar-
ent expression signature when considering the entire life
cycle of the organism. For functions such as DNA pack-
aging (GO:0006323) however, the highest TDR  is
achieved with the LLHB3 data set [27] because the func-
tion is better monitored at the cell cycle level.
We estimated the amount of new information provided
by PlasmoDraft in a systematic way. For the BP ontology,
PlasmoDraft proposes significant annotations on GO
terms of low prior probability (below 25%) for 3 900
genes, among which 2 434 have no BP annotations in
GeneDB. With CC and MF ontologies, 1 905 and 1 540
uncharacterized genes are annotated by PlasmoDraft on
low prior probability GO terms, respectively. The interest
of these annotations of course depends on the associated
GDB. Thus, given a GDB  threshold (e.g. 75%) and an
ontology, for each uncharacterized gene in this ontology
we searched the GO term with the lowest prior probability
wherein the gene is predicted with a statistically signifi-
cant GDB above the threshold. Figure 7 summarizes these
results on the three ontologies. From this figure we see, for
example, that for the BP ontology 290 uncharacterized
genes in GeneDB are predicted with a GDB above 75%
(red curve) on a GO term with a prior probability below
0.10. In the same manner, 1 025 uncharacterized genes
are predicted with a GDB above 50% (blue curve) on a
GO term with a prior probability below 0.25. For the CC
An extract of predictions achieved for gene PFD1015c in the BP ontology Figure 4
An extract of predictions achieved for gene PFD1015c in the BP ontology. The "no" entry indicates that the data 
source does not support the prediction, while "-" means that no data are available in the source for this gene. By clicking on a 
TDR, the K characterized nearest neighbors that support/do not support this prediction are shown (Figure 1). Clicking on any 
term opens the corresponding GO term view.BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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and MF ontologies, 740 and 329 genes are predicted with
a GDB above 50% on a GO term with a prior probability
below 0.25, respectively. Note that only genes without
any annotation in GeneDB in the selected ontology are
considered in this measure, while the PlasmoDraft data-
base also provides additional annotations for many genes
that are already annotated in this ontology. By comparing
the results achieved on the different ontologies, we see
that the BP ontology provides the best results. This is not
surprising, as the signature detected in the postgenomic
data by GBA methods are mostly characteristic of biologi-
cal processes [8]. However, by an information propaga-
tion phenomenon, the BP signatures may sometimes help
for predicting annotations in the two other ontologies.
This happens, for example, when many genes with a given
molecular function (or exported in a particular cellular
component) are involved in a biological process with a
strong signature. For example. GO term host cell
plasma membrane (GO:0020002) in the CC ontol-
ogy is associated with high GDB (72%), because most
genes belonging to this term are also associated with the
biological process Defense response
(GO:0006952) which is well recognized.
A similar approach can be used to estimate the amount of
new information provided by each data source independ-
ently. For example, Figure 8 reports the number of unchar-
acterized genes in the BP ontology that can be annotated
with a TDR above 75%, 50% and 25% by the transcrip-
tomic data of Bozdech et al. (2003) [27], and by the inter-
actomic data of LaCount et al. (2005) [33]. We can see
that more than 73 genes are associated with a GO term of
prior probability below 10% with a TDR above 50% using
the transcriptomic data, while 10 genes only are predicted
with the same thresholds using interactomic data. This
indicates that the interactome tends to provide less func-
tional signal than the transcriptome, partly because less
genes are monitored.
Gonna performance on yeast Figure 5
Gonna performance on yeast. Gonna was applied to the transcriptomic data set published by Spellman et al. (1998) [34] 
using experimental evidence code annotations only as prior knowledge database. TDRs of all BP GO terms where predictions 
are proposed by Gonna are plotted as a function of the prior probability of the terms. Red and black points indicate significant 
and non-significant TDRs, respectively.BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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Assessment of the GDBs
TDRs and GDBs are estimated by cross-validation by
applying Gonna on the already characterized genes. This
procedure produces unbiased estimates of the method
accuracy, provided that the uncharacterized genes share
approximately the same distribution as the characterized
ones [19]. However, since TDRs and GDBs are sometimes
estimated on small numbers of predictions, users should
be aware that for some specific GO terms, the accuracy on
the uncharacterized genes may differ from the reported
TDRs and GDBs. Nonetheless, these measures provide val-
uable indications on the potential functions of genes by
pointing out the most likely GO terms. To assess this
point, we compared the PlasmoDraft predictions pro-
posed for the uncharacterized genes to the annotations of
their homologous genes in yeast when these are known.
We looked on the 986 genes without BP annotations that
have been predicted with high GDB (above 50%) on spe-
cific BP terms (prior probability below 25%). As expected,
few genes among these 986 can be associated with a char-
acterized orthologous gene in S. cerevisiae. However, a
reciprocal best hit procedure using BLASTP with an e-
value cutoff of 10-5 allows to find S. cerevisiae orthologues
for 141 genes. Among these 141 orthologous pairs, 63
(45%) have "concordant" annotations with the high GDB
predictions. Here we consider that annotations are con-
cordant if at least half of the terms with prior probability
below 25% are shared by the S. cerevisiae orthologue. As
expected, this proportion decreases when using Plasmo-
Draft predictions with lower GDBs. For example, 2 271
genes without BP annotations are predicted with a GDB
between 25% and 50% on a GO term with prior probabil-
ity below 25%. Among these, 245 can be associated with
S. cerevisiae orthologues by reciprocal best hit, and 71
(29%) have concordant annotations.
Comparison with the predictions of Zhou et al. (2008) [35]
During the writing of this article, another database [35] of
gene function predictions based on the OPI method
described in reference [17] was published. Briefly, OPI is
Gonna performances on the transcriptomic data set published in Bozdech et al Figure 6
Gonna performances on the transcriptomic data set published in Bozdech et al. (2003) [27]. TDRs of all BP GO 
terms where predictions are proposed by Gonna are plotted as a function of the prior-probability of the terms. Red and black 
points indicate significant and non-significant TDRs, respectively.BMC Bioinformatics 2008, 9:440 http://www.biomedcentral.com/1471-2105/9/440
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a supervised method that works as follows. For each GO
term, OPI uses a set of "seed" genes already annotated
with this term to construct an average expression profile.
Next, all genes (annotated or not) are ranked according to
their similarity to this average profile and a statistical test
is used to identify the rank cutoff that includes the largest
number of seed genes within the smallest cluster size. All
genes before this cutoff are then considered as potentially
related to the GO term under consideration. The database
[35] exploits a single new transcriptomic data set covering
all life cycle stages of the parasite and combining gene
expressions from both P. yoelii and P. falciparum. As both
the methods and data sources are different, this database
and PlasmoDraft provide different and complementary
information. OPI provides BP annotations for 1 902 dif-
ferent genes, among which 1 036 have no BP annotations
in GeneDB. When looking at the PlasmoDraft predictions
with GDB above 50% (which involves 1 111 uncharacter-
ized genes in BP), only 230 also have BP predictions in
OPI. However, when both methods propose BP predic-
tions for a gene, the predictions are often similar. Indeed,
of the 230 common genes, 94 have concordant predic-
tions – i.e. at least half of the predictions of one of the
methods involving terms with a prior probability below
25% are also predicted by the other method. Differences
in specificity of OPI and PlasmoDraft can also be
observed by comparing the GDB and FDR (false discovery
rate) estimates associated with a given GO term by Plasm-
oDraft and OPI, respectively. Recall that the GDB is actu-
ally the TDR associated with the predictor that combines
all data sources. Moreover, by definition, the FDR equals
1 minus the TDR on this term. While FDRs of OPI are not
estimated by cross-validation, we can nevertheless get a
rough idea of which method provides the best results for
a given GO term. For example, OPI obtains the highest
TDRs on terms like Entry into host
(GO:0044409), or Mitochodrion organization
and biogenesis (GO:0007005) (~90% and ~30%
vs. 36% and ~5%), while for terms like Interaction
between organisms (GO:0044419) or Rosetting
(GO:0020013), PlasmoDraft obtains the best results
(77% and 78% vs. 25% and no statistically significant
TDR). On the whole, it thus appears that the two data-
bases use quite different data sources and provide interest-
ing information on different types of functions and
different genes, so the community will likely benefit from
both.
Conclusion
We presented PlasmoDraft, an extensive database of GO
annotation predictions that are achieved by Guilt By Asso-
ciation using most postgenomic data available to date for
P. falciparum. All predictions come with a confidence esti-
mate computed by cross-validation. The database is pre-
sented in a friendly interface that allows easy browsing
Estimate of the amount of new information supplied in Plas- moDraft Figure 7
Estimate of the amount of new information supplied 
in PlasmoDraft. Estimates for the BP (up) CC (middle) and 
MF (down) ontologies. Red, blue and green lines represent 
the results achieved with GDB thresholds of 75%, 50% and 
25%, respectively. The x-axis gives the prior probabilities of 
the terms, while the y-axis (in log scale) reports the number 
of uncharacterized genes in the ontology that have been pre-
dicted with a GDB above the threshold, on a GO term with 
prior probability below x.
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Estimate of the amount of new information supplied by the transcriptomic data source of Bozdech et al Figure 8
Estimate of the amount of new information supplied by the transcriptomic data source of Bozdech et al. 
(2003) [27] and the interactomic data source of LaCount et al. (2005) [33]. Red, blue and green lines represent the 
results achieved with TDR thresholds of 75%, 50% and 25%, respectively. The x-axis gives the prior probabilities of the terms, 
while the y-axis (in log scale) reports the number of uncharacterized genes in the ontology that have been predicted with a TDR 
above the threshold, on a GO term with prior probability below x.
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and querying, and proposes high confidence annotations
for several hundreds of genes without any annotations, as
well as additional annotations for many already character-
ized genes. One prospect is the integration of compendiums
of gene expression data sets as new data sources in Plasm-
oDraft. These data, obtained by concatenation of several
data sets of diversified biological conditions, have shown
to often provide strong biological function signatures
[36]. However, predictions based on these data may be
difficult to interpret for biologists, and their integration
opens new issues in data selection and combination.
As mentioned in the Methods, one advantage of Gonna
concerns its genericness that allows its use on any new
data, as long as a relevant similarity measure can be com-
puted; a set of scripts then enables regeneration of the
database to integrate the new data set in a fully automated
way. This also holds for the GO annotations used as prior
knowledge, and the new annotations provided by the
community in the future will be easily integrated. Most
notably, we are aware that a collegiate effort for re-anno-
tating P. falciparum proteins should provide new/curated
functional annotations in the near future. This should
improve both the quantity and the quality of the Plasmo-
Draft predictions. In the same way, while in the current
version of PlasmoDraft all GO annotations are considered
(i.e. including automatically-assigned annotations) due to
the scarcity of curated annotations, it is possible that the
re-annotation effort will enable the use of only curator-
assigned annotations in the subsequent versions of Plas-
moDraft. Thanks to these new advances, PlasmoDraft
should become more and more accurate and useful to the
community.
Availability and requirements
PlasmoDraft is freely available at http://atgc.lirmm.fr/
PlasmoDraft/
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